What is Cyclogest used for in pregnancy?
Cyclogest can be used during the first trimester of pregnancy for women who need extra progesterone while undergoing treatment in an Assisted Reproductive Technology (ART) programme.
What is Cyclogest used for?
Cyclogest 400mg Pessaries is used to restore menstrual cycles in women whose periods have stopped. It is a natural female hormone important for regulating ovulation (release of an egg from a woman’s ovary) and menstruation. It is also used in the treatment of infertility to help you get pregnant.
Is it safe to take Cyclogest during pregnancy?
Cyclogest contains the hormone progesterone which is present in significant concentrations in women during the second half of the menstrual cycle and during pregnancy. This should be borne in mind when treating patients with conditions that may be hormone-sensitive.
Can Cyclogest prevent miscarriage?
Cyclogest is not indicated in threatened miscarriage. Treatment should be discontinued in the event of a missed miscarriage….Hide table of contents.
|SYSTEM ORGAN CLASS||Common||Uncommon|
|Vascular disorders||Hot flush||Haemorrhage|
Why do doctors give progesterone during pregnancy?
Progesterone is a hormone that helps the uterus grow during pregnancy and keeps it from contracting. Treatment with progesterone during pregnancy may help some people reduce their risk for premature birth. If you have a short cervix, treatment with vaginal progesterone gel may help prevent premature birth.
Does Cyclogest stop your period?
Cyclogest | Health24. It is possible that Cyclogest could delay a period. However, if do not fall pregnant, then cyclogest may not delay your period and menstruation will begin soon. If a high dose of cyclogest is taken then the period will only come on once you have stopped the cyclogest.
Which injection is used to prevent miscarriage?
Progesterone injections are often prescribed for pregnant women who’ve experienced a miscarriage or multiple miscarriages.
Can Cyclogest affect my baby?
Cyclogest should not be used during pregnancy. There is limited and inconclusive data on the risk of congenital anomalies, including genital abnormalities in male or female infants, following intrauterine exposure during pregnancy.